Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Integrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough
Woman and Man Max 99 years
Integrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough
Update Il y a 4 ans
A Randomized, Open-label, Multi-center, Phase 3, 2-arm Study Evaluating the Efficacy and Safety of Peg interferon Alfa-2b Low-dose Maintenance Monotherapy Versus Standard Supportive Care in Patients With Cirrhotic Hepatitis C Co-infected With Human Immunodeficiency Virus – The ENDURE Study
To compare throughout the study the efficacy of PEG-Intron® monotherapy versus standard supportive care, using the time to the first occurrence of any one of the following clinical events (death, live...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Integrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough
Update Il y a 4 ans
Comparison of Three Regimens of PEG-Intron plus Ribavirin in the Treatment of Chronic Hepatitis C, Genotype 2 or 3, in Previously Untreated Patients
To examine the effect of peg-Intron dose by comparing the "standard" regimen, peg-Intron 1.5 mcg/kg qW sc plus ribavirin 800-1200 mg daily, to a lower dose regimen, peg-Intron 1.0 mcg/kg qW sc plus ri...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Integrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough
Update Il y a 4 ans
Efficacy and Safety of PEG-Intron plus Rebetol in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys
The objective of this study is to determine the proportion of chronic hepatitis C genotype 1 subjects who did not respond to previous treatment with Pegasys 180µg QW plus ribavirin, that will achieve ...
Country
None
organs
None
Specialty
None
Closed trial
More information